S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis.
<h4>Background and aims</h4>Bile analysis has the potential to serve as a surrogate marker for inflammatory and neoplastic disorders of the biliary epithelium and may provide insight into biliary pathophysiology and possible diagnostic markers. We aimed to identify biliary protein marker...
Guardado en:
Autores principales: | Lisa Reinhard, Christian Rupp, Hans-Dieter Riedel, Thomas Ruppert, Thomas Giese, Christa Flechtenmacher, Karl Heinz Weiss, Petra Kloeters-Plachky, Wolfgang Stremmel, Peter Schirmacher, Peter Sauer, Daniel Nils Gotthardt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4c9a56774a794a25ad324c6ba31a69cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biomarkers for primary biliary cholangitis: current perspectives
por: Kouroumalis E, et al.
Publicado: (2018) -
Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis
por: Agnieszka Kempinska-Podhorodecka, et al.
Publicado: (2021) -
Clinical Features and Outcomes of Primary Sclerosing Cholangitis in the Highly Admixed Brazilian Population
por: Mateus Jorge Nardelli, et al.
Publicado: (2021) -
Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography
por: Rolf Reiter, et al.
Publicado: (2021) -
NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients
por: Christoph Jüngst, et al.
Publicado: (2017)